180 Life Sciences Corp (ATNF)
2.04
-0.11
(-5.12%)
USD |
NASDAQ |
May 01, 16:00
2.04
0.00 (0.00%)
After-Hours: 20:00
180 Life Sciences Total Return Level: 2.15 for April 30, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 30, 2024 | 2.15 |
April 29, 2024 | 1.96 |
April 26, 2024 | 1.80 |
April 25, 2024 | 1.769 |
April 24, 2024 | 1.82 |
April 23, 2024 | 1.90 |
April 22, 2024 | 1.80 |
April 19, 2024 | 1.820 |
April 18, 2024 | 1.83 |
April 17, 2024 | 1.91 |
April 16, 2024 | 1.48 |
April 15, 2024 | 2.035 |
April 12, 2024 | 2.16 |
April 11, 2024 | 2.22 |
April 10, 2024 | 2.46 |
April 09, 2024 | 2.32 |
April 08, 2024 | 2.315 |
April 05, 2024 | 2.23 |
April 04, 2024 | 2.190 |
April 03, 2024 | 2.26 |
April 02, 2024 | 2.10 |
April 01, 2024 | 2.20 |
March 28, 2024 | 2.33 |
March 27, 2024 | 2.01 |
March 26, 2024 | 1.96 |
Date | Value |
---|---|
March 25, 2024 | 2.110 |
March 22, 2024 | 2.77 |
March 21, 2024 | 3.48 |
March 20, 2024 | 3.31 |
March 19, 2024 | 3.22 |
March 18, 2024 | 3.38 |
March 15, 2024 | 3.50 |
March 14, 2024 | 3.58 |
March 13, 2024 | 3.58 |
March 12, 2024 | 4.02 |
March 11, 2024 | 3.88 |
March 08, 2024 | 3.53 |
March 07, 2024 | 4.12 |
March 06, 2024 | 3.70 |
March 05, 2024 | 3.84 |
March 04, 2024 | 3.392 |
March 01, 2024 | 3.23 |
February 29, 2024 | 3.52 |
February 28, 2024 | 3.15 |
February 27, 2024 | 3.705 |
February 26, 2024 | 3.798 |
February 23, 2024 | 3.600 |
February 22, 2024 | 3.707 |
February 21, 2024 | 3.635 |
February 20, 2024 | 4.085 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
1.48
Minimum
Apr 16 2024
4552.40
Maximum
Apr 12 2021
1809.19
Average
1204.60
Median
Jan 27 2021
Total Return Level Benchmarks
Seelos Therapeutics Inc | 0.2751 |
Altimmune Inc | 12.33 |
GT Biopharma Inc | 3.00 |
Outlook Therapeutics Inc | 8.92 |
MAIA Biotechnology Inc | 2.93 |